UVA-Riboflavin Crosslinking Treatment of Corneal Ectasia
Status:
Unknown status
Trial end date:
2014-05-01
Target enrollment:
Participant gender:
Summary
The primary objective of this study is to evaluate two different ultraviolet (UV) dosing
regimens for corneal collagen cross linking to slow the progressive changes in corneal
curvature in eyes with progressive keratoconus or post-refractive surgery ectasia.